Dose Intensification of Daunorubicin and Cytarabine during Treatment of Adult Acute Lymphoblastic Leukemia: Results of Cancer and Leukemia Group B Study 19802
      QxMD      Google Scholar   
Citation:
Cancer vol 119 (1) 90-98
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
2
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
CA02599, CA03927, CA101140, CA31946, CA32291, CA33601, CA35279, CA41287, CA77658, P30 CA012197, U10 CA003927, U10 CA031946, U10 CA032291, U10 CA033601, U10 CA035279, U10 CA041287, U10 CA077658, U10 CA101140  
Corr. Author:
 
Authors:
                             
Networks:
 
Study
CALGB-19802
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Article